Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NantOmics is a leader in molecular diagnostics, offering a proprietary, integrated panomic analysis platform that combines DNA sequencing, RNA sequencing, and quantitative proteomics to create comprehensive molecular profiles of individual tumors. This platform is designed to guide personalized treatment decisions in oncology by identifying actionable genomic and proteomic alterations. NantOmics’ technologies have supported clinical trials in lymphoma, breast cancer, and Merkel cell carcinoma, and the company has developed scalable cloud-based infrastructure for high-throughput, near real-time genomic analysis[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NantOmics.